Mehmet H. Kocoglu

2.3k citations
60 papers · 996 indexed · h-index 15

Mehmet H. Kocoglu

54 papers receiving 987 citations

Peers

Mehmet H. Kocoglu
Comparison fields: 5 of 70
  • Hematology 455
  • Oncology 605
  • Immunology 243
  • Infectious Diseases 134
  • Genetics 64
Replace Don A. Stevens with:
Don A. Stevens United States
Maaike Nederend Netherlands
Maureen Ward United States
Nahoko Suzuki Japan
Jooeun Bae United States
Patrick Schlegel Germany
Mobin Karimi United States
Bart Nijmeijer Netherlands
Jan Martínek United States
Susann Szmania United States
Mehmet H. Kocoglu relative to Don A. Stevens United States Don A. Stevens's profile →
Citations per field
00.5×10×15×20×23.8×
Don A. Stevens · 1×
Citations per year

Countries citing papers authored by Mehmet H. Kocoglu

Since Specialization
Citations

This map shows the geographic impact of Mehmet H. Kocoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mehmet H. Kocoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mehmet H. Kocoglu more than expected).

Fields of papers citing papers by Mehmet H. Kocoglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mehmet H. Kocoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mehmet H. Kocoglu. The network helps show where Mehmet H. Kocoglu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mehmet H. Kocoglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mehmet H. Kocoglu Line = papers co-authored together Mehmet H. Kocoglu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20240
4 20242
5 20242
6 20245
7 20231
8 20223
9 20224
10 202211
11 202071
12 202015
13 20196
14 2017146
15 20170
16 20171
17 2016116
18 20151
19 201341
20 200910

About Mehmet H. Kocoglu

Mehmet H. Kocoglu is a scholar working on Hematology, Oncology and Genetics, having authored 60 papers that have together received 996 indexed citations. Recurring topics across this work include CAR-T cell therapy research (30 papers), Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (12 papers), Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Biosimilars and Bioanalytical Methods (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Hematology (455 citations), Oncology (605 citations) and Immunology (243 citations). Mehmet H. Kocoglu has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Ashraf Badros, Aaron P. Rapoport, Zeba N. Singh, Elias Anaissie, Gail L. Woods, Weizhi Zhao, Olga Goloubeva, Marisa H. Miceli, Bart Barlogie and Nancy M. Hardy. Their work appears in journals such as Blood, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, Transplantation and Cellular Therapy and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026